Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Polycystic Ovary Syndrome 52Infertility 22Anovulation 11Vitamin D Deficiency 2Rare Diseases 2Hyperinsulinism 2Hyperandrogenism 2Endocrine System Diseases 2Prolactinoma 1Primary Ovarian Insufficiency 1Pathologic Processes 1Motor Activity 1Leiomyoma 1Insulin Resistance 1Infertility, Female 1Hypogonadism 1Hyperprolactinemia 1Dry Eye Syndromes 1

Interventions

Cabergoline 6Dopamine Agonists 2ropinirole 1pasireotide 1Tissue Banks 1Temozolomide 1Surgical Procedures, Operative 1Standard of Care 1Microarray Analysis 1Magnetic Resonance Spectroscopy 1Lapatinib 1Early Intervention, Educational 1Dexamethasone 1DNA Methylation 1Clomiphene 1Calcium Dobesilate 12,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Prolactinoma × Clomiphene × Clear all
NCT00697814 2008-06-16

Clomiphene in Males With Prolactinomas and Persistent Hypogonadism

Federal University of São Paulo

Phase 2 Completed
15 enrolled

Hypogonadism, Prolactinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡